Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors.
Andreis S, Basso M, Scaggiante R, Cruciani M, Ferretto R, Manfrin V, Panese S, Rossi MC, Francavilla E, Boldrin C, Alvarez M, Dal Bello F, Mengoli C, Turriziani O, Sarmati L, Antonelli G, Andreoni M, Palù G, Parisi SG. Andreis S, et al. Among authors: dal bello f. J Glob Antimicrob Resist. 2017 Sep;10:106-112. doi: 10.1016/j.jgar.2017.05.011. Epub 2017 Jul 18. J Glob Antimicrob Resist. 2017. PMID: 28732792
Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.
Parisi SG, Boldrin C, Cruciani M, Nicolini G, Cerbaro I, Manfrin V, Dal Bello F, Franchin E, Franzetti M, Rossi MC, Cattelan AM, Romano L, Zazzi M, Andreoni M, Palù G. Parisi SG, et al. Among authors: dal bello f. J Clin Microbiol. 2007 Jun;45(6):1783-8. doi: 10.1128/JCM.00056-07. Epub 2007 Apr 18. J Clin Microbiol. 2007. PMID: 17442799 Free PMC article.
Decreasing trends of drug resistance and increase of non-B subtypes amongst subjects recently diagnosed as HIV-infected over the period 2004-2012 in the Veneto Region, Italy.
Parisi SG, Andreis S, Scaggiante R, Cruciani M, Ferretto R, Manfrin V, Panese S, Rossi MC, Francavilla E, Boldrin C, Dal Bello F, Basso M, Mengoli C, Andreoni M, Palù G. Parisi SG, et al. Among authors: dal bello f. J Glob Antimicrob Resist. 2013 Dec;1(4):201-206. doi: 10.1016/j.jgar.2013.05.008. Epub 2013 Jul 27. J Glob Antimicrob Resist. 2013. PMID: 27873613
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010.
Colafigli M, Torti C, Trecarichi EM, Albini L, Rosi A, Micheli V, Manca N, Penco G, Bruzzone B, Punzi G, Corsi P, Parruti G, Bagnarelli P, Monno L, Gonnelli A, Cauda R, Di Giambenedetto S; ARCA, UCSC and Brescia HIV resistance study groups. Colafigli M, et al. Clin Microbiol Infect. 2012 Aug;18(8):E299-304. doi: 10.1111/j.1469-0691.2012.03847.x. Epub 2012 Apr 27. Clin Microbiol Infect. 2012. PMID: 22536753 Free PMC article.
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin.
Parisi SG, Loregian A, Andreis S, Nannetti G, Cavinato S, Basso M, Scaggiante R, Dal Bello F, Messa L, Cattelan AM, Palù G. Parisi SG, et al. Among authors: dal bello f. Int J Infect Dis. 2016 Aug;49:151-3. doi: 10.1016/j.ijid.2016.06.020. Epub 2016 Jul 1. Int J Infect Dis. 2016. PMID: 27378577 Free article.
113 results